![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3585945231426876830)
surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help
Description
Same number of units, double the dose
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://media.licdn.com/dms/image/v2/D4E10AQFynMXTMGHZvw/image-shrink_800/B4EZkz7UjPKoAk-/0/1757512815493?e=2147483647&v=beta&t=SekbZjACHFy5r-32UCP9aBpuSR3dpwJRqwz4xnbYebs)
Stay hydrated: Drinking plenty of water can help manage side effects and support overall health
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://i0.wp.com/www.cardionerds.com/wp-content/uploads/2022/09/Once-Weekly-Tirzepatide-for-Obesity.png?ssl=1)
Zhou, T
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://static.wixstatic.com/media/1f382d_67b017bcb17540bab22652766148f880~mv2.jpg/v1/fill/w_568,h_170,al_c,lg_1,q_80,enc_avif,quality_auto/1f382d_67b017bcb17540bab22652766148f880~mv2.jpg)
Understanding these mechanisms helps clinicians provide appropriate counselling and implement preventative strategies
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://preview.redd.it/surmount-1-three-year-obesty-diabetes-prevention-outcomes-v0-ps2tayze0dzd1.jpeg?width=1150&format=pjpg&auto=webp&s=185f6ff4dc0d996fe43c91a688d358cd8d559411)
Whether you need an endoscopy or a Colonoscopy in Gurgaon, you are in safe and expert hands.
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://ars.els-cdn.com/content/image/1-s2.0-S014067362301200X-gr3.jpg)
If you are of Asian descent and your BMI falls between 23 and 30, have a detailed conversation with your provider about ethnicity-adjusted risk assessment
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight The SURMOUNT-MAINTAIN trial will help](https://www.researchgate.net/publication/374748518/figure/fig4/AS:11431281226179337@1709094754022/SURMOUNT-3-study-design-This-is-a-phase-3-multicenter-randomized-placebo-controlled.jpg)
